SARAH GARROTT: Open Payments
NPI 1649515917 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,262 in 121 payments from 14 companies in 2025. Trend: 2023 $1,979 · 2024 $1,506 · 2025 $2,262
Food & beverage: $2,262
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $587 |
| Janssen Biotech, Inc. | 15 | $281 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $231 |
| Gilead Sciences, Inc. | 10 | $206 |
| Madrigal Pharmaceuticals | 11 | $169 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $165 |
| Intercept Pharmaceuticals, Inc. | 9 | $159 |
| Lilly USA, LLC | 5 | $131 |
| Ipsen Biopharmaceuticals, Inc | 6 | $128 |
| Celltrion USA Inc. | 3 | $57 |
Products named: RINVOQ, TREMFYA, REZDIFFRA, OCALIVA, LINZESS, XIFAXAN, ENTYVIO, IQIRVO.
Industry payments across MO — which companies pay providers there.
